Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic

The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of cancer research 2020-01, Vol.10 (8), p.2282-2292
Hauptverfasser: Zhao, Wensi, Qiu, Hu, Gong, Yi, Han, Chen, Ruan, Shasha, Wang, Chenyu, Chen, Jiamei, Ke, Shaobo, Shi, Wei, Wang, Jing, Xu, Qiuni, Li, Yan, Shi, Yuxia, Chen, Qian, Chen, Yongshun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2292
container_issue 8
container_start_page 2282
container_title American journal of cancer research
container_volume 10
creator Zhao, Wensi
Qiu, Hu
Gong, Yi
Han, Chen
Ruan, Shasha
Wang, Chenyu
Chen, Jiamei
Ke, Shaobo
Shi, Wei
Wang, Jing
Xu, Qiuni
Li, Yan
Shi, Yuxia
Chen, Qian
Chen, Yongshun
description The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7471365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2441601166</sourcerecordid><originalsourceid>FETCH-LOGICAL-p196t-6d2d1fe76892b03741452fd27b56d715f8bca01c8cbee585bba331484354ff053</originalsourceid><addsrcrecordid>eNpVkE1PwzAMhisEYtPYX0A5cqmUNF_NBQmVr0mTdgGuUZomW1CblqRD4t-TsoGGL7bsx-9r-SybF4iynAnOzk_qWbaM8R2mIBAJIi6zGS4EpBSSeear1nmnVQt076NrTFCjSxWwfQDjzoBOebU1nfEj6C3QymsTwJCg1InA-QPkRrf9WQRxTPiETv1q87a6z5FIC74xndNX2YVVbTTLY15kr48PL9Vzvt48raq7dT4gwcacNUWDrOGsFEUNMSeI0MI2Ba8paziitqy1gkiXujaGlrSuFcaIlARTYi2keJHdHnSHfd2ZRqdjg2rlEFynwpfslZP_J97t5Lb_lJxwhNkkcHMUCP3H3sRRdi5q07bKm34fZUEIYhAhxhJ6fer1Z_L7ZPwNQN57nw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2441601166</pqid></control><display><type>article</type><title>Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Zhao, Wensi ; Qiu, Hu ; Gong, Yi ; Han, Chen ; Ruan, Shasha ; Wang, Chenyu ; Chen, Jiamei ; Ke, Shaobo ; Shi, Wei ; Wang, Jing ; Xu, Qiuni ; Li, Yan ; Shi, Yuxia ; Chen, Qian ; Chen, Yongshun</creator><creatorcontrib>Zhao, Wensi ; Qiu, Hu ; Gong, Yi ; Han, Chen ; Ruan, Shasha ; Wang, Chenyu ; Chen, Jiamei ; Ke, Shaobo ; Shi, Wei ; Wang, Jing ; Xu, Qiuni ; Li, Yan ; Shi, Yuxia ; Chen, Qian ; Chen, Yongshun</creatorcontrib><description>The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.</description><identifier>ISSN: 2156-6976</identifier><identifier>EISSN: 2156-6976</identifier><identifier>PMID: 32905504</identifier><language>eng</language><publisher>United States: e-Century Publishing Corporation</publisher><subject>Review</subject><ispartof>American journal of cancer research, 2020-01, Vol.10 (8), p.2282-2292</ispartof><rights>AJCR Copyright © 2020.</rights><rights>AJCR Copyright © 2020 2020</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471365/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471365/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32905504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Wensi</creatorcontrib><creatorcontrib>Qiu, Hu</creatorcontrib><creatorcontrib>Gong, Yi</creatorcontrib><creatorcontrib>Han, Chen</creatorcontrib><creatorcontrib>Ruan, Shasha</creatorcontrib><creatorcontrib>Wang, Chenyu</creatorcontrib><creatorcontrib>Chen, Jiamei</creatorcontrib><creatorcontrib>Ke, Shaobo</creatorcontrib><creatorcontrib>Shi, Wei</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Xu, Qiuni</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Shi, Yuxia</creatorcontrib><creatorcontrib>Chen, Qian</creatorcontrib><creatorcontrib>Chen, Yongshun</creatorcontrib><title>Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic</title><title>American journal of cancer research</title><addtitle>Am J Cancer Res</addtitle><description>The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.</description><subject>Review</subject><issn>2156-6976</issn><issn>2156-6976</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PwzAMhisEYtPYX0A5cqmUNF_NBQmVr0mTdgGuUZomW1CblqRD4t-TsoGGL7bsx-9r-SybF4iynAnOzk_qWbaM8R2mIBAJIi6zGS4EpBSSeear1nmnVQt076NrTFCjSxWwfQDjzoBOebU1nfEj6C3QymsTwJCg1InA-QPkRrf9WQRxTPiETv1q87a6z5FIC74xndNX2YVVbTTLY15kr48PL9Vzvt48raq7dT4gwcacNUWDrOGsFEUNMSeI0MI2Ba8paziitqy1gkiXujaGlrSuFcaIlARTYi2keJHdHnSHfd2ZRqdjg2rlEFynwpfslZP_J97t5Lb_lJxwhNkkcHMUCP3H3sRRdi5q07bKm34fZUEIYhAhxhJ6fer1Z_L7ZPwNQN57nw</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Zhao, Wensi</creator><creator>Qiu, Hu</creator><creator>Gong, Yi</creator><creator>Han, Chen</creator><creator>Ruan, Shasha</creator><creator>Wang, Chenyu</creator><creator>Chen, Jiamei</creator><creator>Ke, Shaobo</creator><creator>Shi, Wei</creator><creator>Wang, Jing</creator><creator>Xu, Qiuni</creator><creator>Li, Yan</creator><creator>Shi, Yuxia</creator><creator>Chen, Qian</creator><creator>Chen, Yongshun</creator><general>e-Century Publishing Corporation</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200101</creationdate><title>Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic</title><author>Zhao, Wensi ; Qiu, Hu ; Gong, Yi ; Han, Chen ; Ruan, Shasha ; Wang, Chenyu ; Chen, Jiamei ; Ke, Shaobo ; Shi, Wei ; Wang, Jing ; Xu, Qiuni ; Li, Yan ; Shi, Yuxia ; Chen, Qian ; Chen, Yongshun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p196t-6d2d1fe76892b03741452fd27b56d715f8bca01c8cbee585bba331484354ff053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Wensi</creatorcontrib><creatorcontrib>Qiu, Hu</creatorcontrib><creatorcontrib>Gong, Yi</creatorcontrib><creatorcontrib>Han, Chen</creatorcontrib><creatorcontrib>Ruan, Shasha</creatorcontrib><creatorcontrib>Wang, Chenyu</creatorcontrib><creatorcontrib>Chen, Jiamei</creatorcontrib><creatorcontrib>Ke, Shaobo</creatorcontrib><creatorcontrib>Shi, Wei</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Xu, Qiuni</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Shi, Yuxia</creatorcontrib><creatorcontrib>Chen, Qian</creatorcontrib><creatorcontrib>Chen, Yongshun</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Wensi</au><au>Qiu, Hu</au><au>Gong, Yi</au><au>Han, Chen</au><au>Ruan, Shasha</au><au>Wang, Chenyu</au><au>Chen, Jiamei</au><au>Ke, Shaobo</au><au>Shi, Wei</au><au>Wang, Jing</au><au>Xu, Qiuni</au><au>Li, Yan</au><au>Shi, Yuxia</au><au>Chen, Qian</au><au>Chen, Yongshun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic</atitle><jtitle>American journal of cancer research</jtitle><addtitle>Am J Cancer Res</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>10</volume><issue>8</issue><spage>2282</spage><epage>2292</epage><pages>2282-2292</pages><issn>2156-6976</issn><eissn>2156-6976</eissn><abstract>The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.</abstract><cop>United States</cop><pub>e-Century Publishing Corporation</pub><pmid>32905504</pmid><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2156-6976
ispartof American journal of cancer research, 2020-01, Vol.10 (8), p.2282-2292
issn 2156-6976
2156-6976
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7471365
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Review
title Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A31%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20considerations%20for%20the%20management%20of%20cancer%20patients%20in%20the%20mitigation%20stage%20of%20the%20COVID-19%20pandemic&rft.jtitle=American%20journal%20of%20cancer%20research&rft.au=Zhao,%20Wensi&rft.date=2020-01-01&rft.volume=10&rft.issue=8&rft.spage=2282&rft.epage=2292&rft.pages=2282-2292&rft.issn=2156-6976&rft.eissn=2156-6976&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2441601166%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2441601166&rft_id=info:pmid/32905504&rfr_iscdi=true